Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used benralizumab, according to a poster presented here. Lower blood eosinophil counts ...

Platkin. Giuseppe Mandara, 55, was a 15-year veteran of the state corrections department at the time of the incident. He had previously pleaded guilty to aggravated assault. More local news ...

Unlimited Potential - Make This Your Dream Home! Seize this exceptional beachside opportunity and embrace a lifestyle of unparalleled charm. Nestled in the highly sought-after beachside enclave of ...

Baloxavir marboxil for influenza prophylaxis in people aged 12 and over [ID3793] Technology appraisal guidance Baloxavir marboxil for treating influenza in babies under 1 year [TSID12141] Technology ...

Baloxavir marboxil for treating influenza in babies under 1 year [TSID12141] Technology appraisal guidance Baloxavir marboxil for treating influenza in people at high risk of complications [ID3794] ...

AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...

Baloxavir marboxil for influenza prophylaxis in people aged 12 and over [ID3793] Technology appraisal guidance Baloxavir marboxil for treating influenza in people at high risk of complications [ID3794 ...

Durvalumab with tremelimumab and chemotherapy for treating unresectable or advanced urothelial cancer [ID3855] Technology appraisal guidance Tiragolumab in combination for untreated advanced ...

Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261] Technology appraisal guidance TBC Avelumab with axitinib for untreated advanced renal cell carcinoma ...